Raskin P, Klaff L, McGill J, South SA, Hollander P, Khutoryansky N, Hale PM, for the Repaglinide vs. Nateglinide Metformin Combination Study Group: Efficacy and safety of combination therapy: repaglinide plus metformin versus nateglinide plus metformin. Diabetes Care 26:2063–2068, 2003

In Fig. 1B of the above-listed article, the solid and dashed lines were inadvertently switched. The corrected figure is shown here.

Jacob G, Costa F, Biaggioni I: Spectrum of autonomic cardiovascular neuropathy in diabetes. Diabetes Care 26:2174–2180, 2003

In Table 1 of the above-listed article, the mean ± SE upright heart rate for hyperadrenergic patients should have been given as 103 ± 5 bpm.

Figure 1B—

Mean FPG values during treatment. SE values are indicated by bars. *FPG values in the two treatment groups were significantly different (P < 0.05).

Figure 1B—

Mean FPG values during treatment. SE values are indicated by bars. *FPG values in the two treatment groups were significantly different (P < 0.05).

Close modal